Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Kelly Kennewick

Title(s)Postdoctoral Scholar - Research Associate
SchoolKeck School of Medicine of Usc
Address2011 Zonal Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models. Commun Biol. 2025 Apr 04; 8(1):562. Sammarco A, Guerra G, Eyme KM, Kennewick K, Qiao Y, El Hokayem J, Williams KJ, Su B, Cakici C, Mnatsakanyan H, Zappulli V, Bensinger SJ, Badr CE. PMID: 40185889; PMCID: PMC11971295.
      View in: PubMed   Mentions: 1  Translation:HumansAnimalsCells
    2. Disrupting cholesterol homeostasis in T cells boosts antitumour responses. Nat Metab. 2025 Mar; 7(3):441-443. Kennewick KT, Bensinger SJ. PMID: 40065101.
      View in: PubMed   Mentions:    Fields:    
    3. Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models. bioRxiv. 2024 May 09. Sammarco A, Guerra G, Eyme KM, Kennewick K, Qiao Y, Hokayem JE, Williams KJ, Su B, Zappulli V, Bensinger SJ, Badr CE. PMID: 38766019; PMCID: PMC11100738.
      View in: PubMed   Mentions:
    4. Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells. Mol Ther Oncol. 2024 Jun 20; 32(2):200789. Kennewick KT, Yamaguchi Y, Gibson J, Gerdts EA, Jeang B, Tilakawardane D, Murad JP, Chang WC, Wright SL, Thiel MS, Forman SJ, Stern LA, Priceman SJ. PMID: 38939825; PMCID: PMC11208731.
      View in: PubMed   Mentions:
    5. Metabolic programs of T cell tissue residency empower tumour immunity. Nature. 2023 09; 621(7977):179-187. Reina-Campos M, Heeg M, Kennewick K, Mathews IT, Galletti G, Luna V, Nguyen Q, Huang H, Milner JJ, Hu KH, Vichaidit A, Santillano N, Boland BS, Chang JT, Jain M, Sharma S, Krummel MF, Chi H, Bensinger SJ, Goldrath AW. PMID: 37648857; PMCID: PMC11238873.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    6. Decoding the crosstalk between mevalonate metabolism and T cell function. Immunol Rev. 2023 08; 317(1):71-94. Kennewick KT, Bensinger SJ. PMID: 36999733; PMCID: PMC12136499.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    7. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol Ther. 2021 07 07; 29(7):2335-2349. Murad JP, Tilakawardane D, Park AK, Lopez LS, Young CA, Gibson J, Yamaguchi Y, Lee HJ, Kennewick KT, Gittins BJ, Chang WC, Tran CP, Martinez C, Wu AM, Reiter RE, Dorff TB, Forman SJ, Priceman SJ. PMID: 33647456; PMCID: PMC8261088.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    8. Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. Oncoimmunology. 2018; 7(2):e1380764. Priceman SJ, Gerdts EA, Tilakawardane D, Kennewick KT, Murad JP, Park AK, Jeang B, Yamaguchi Y, Yang X, Urak R, Weng L, Chang WC, Wright S, Pal S, Reiter RE, Wu AM, Brown CE, Forman SJ. PMID: 29308300; PMCID: PMC5749625.
      View in: PubMed   Mentions: 94     Fields:    
    Kelly's Networks
    Concepts (40)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-18-gb39b692b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.